Cai Xu-ling, Gao Yan-hui, Yu Zhuo-wen, Wu Zhao-quan, Zhou Wei-ping, Yang Yi, Xu Ya, Song Shao-fang, Chen Si-dong
Public Health College, Guangdong College of Pharmacy, Guangzhou 510310, China.
Zhonghua Liu Xing Bing Xue Za Zhi. 2009 Sep;30(9):942-5.
To evaluate the interaction between environmental factors, HBV/HCV infections and DNA repair gene XPC exon 8 Ala499Val, exon 15 Lys939Gln on related risks to primary hepatocellular carcinoma (PHC).
A 1:1 matched case-control study was conducted in Shunde city, Guangdong province. The genotypes of Ala499Val and Lys939Gln were detected by polymerase chain reaction restrictive fragment length polymorphism (PCR-RFLP) analysis, and gene-environment interactions were analyzed by conditional logistic regression.
Among people infected by HBV with non- or at least one mutant gene of Ala499Val carriers, the risk of PHC significantly increased, with ORs as 3.768 (95%CI: 1.137 - 12.485) and 3.667(95%CI: 1.122 - 11.981) respectively. With non- or at least one mutant gene of Lys939Gln, the risk was increasing with ORs as 6.778 (95%CI: 2.025 - 22.688) and 3.152 (95%CI: 1.062 - 9.351) respectively. In those with HCV infection, non- or at least one mutant gene of Ala499Val might increase the risk with ORs as 2.955 (95%CI: 0.587 - 14.869), 1.085(95%CI: 0.307 - 3.839) respectively. However, when compared to the ones with no mutant gene of Lys939Gln among the same research subjects, those carrying at least one gene may decrease the risk, with OR lowered from 4.197 (95%CI: 0.870 - 20.243) to 0.887 (95%CI: 0.228 - 3.448). But the interactions between HBV infection, HCV infection and XPC genes were not statistically significant.
Among people infected by HCV, the mutant gene of Ala499Val had the tendency to lower the risk of PHC, and the mutant gene of Lys939Gln also appeared the same in the population with either HBV infection or HCV infection in Shunde, Guangdong. Another study with large samples should be performed to analyze the interactions among environments-genes.
评估环境因素、HBV/HCV感染与DNA修复基因XPC外显子8 Ala499Val、外显子15 Lys939Gln之间的相互作用对原发性肝细胞癌(PHC)相关风险的影响。
在广东省顺德市进行1:1匹配的病例对照研究。采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)分析法检测Ala499Val和Lys939Gln的基因型,并通过条件logistic回归分析基因-环境相互作用。
在感染HBV且携带Ala499Val非突变或至少一个突变基因的人群中,PHC风险显著增加,OR值分别为3.768(95%CI:1.137 - 12.485)和3.667(95%CI:1.122 - 11.981)。携带Lys939Gln非突变或至少一个突变基因时,风险也增加,OR值分别为6.778(95%CI:2.025 - 22.688)和3.152(95%CI:1.062 - 9.351)。在感染HCV的人群中,携带Ala499Val非突变或至少一个突变基因可能增加风险,OR值分别为2.955(95%CI:0.587 - 14.869)、1.085(95%CI:0.307 - 3.839)。然而,在同一研究对象中,与未携带Lys939Gln突变基因的人相比,携带至少一个该基因的人风险可能降低,OR值从4.197(95%CI:0.870 - 20.243)降至0.887(95%CI:0.228 - 3.448)。但HBV感染、HCV感染与XPC基因之间的相互作用无统计学意义。
在感染HCV的人群中,Ala499Val突变基因有降低PHC风险的趋势,在广东顺德感染HBV或HCV的人群中,Lys939Gln突变基因也有同样趋势。应进行另一项大样本研究以分析环境-基因之间的相互作用。